| Literature DB >> 29973484 |
Junjun Meng1,2, Wei Cheng3, Hajar Heydari4, Bin Wang5, Kui Zhu6, Belma Konuklugil7, Wenhan Lin8.
Abstract
Antibacterial activity assessment and high performance liquid chromatography associated with nuclear magnetic resonance (HPLC/NMR) data revealed that the EtOAc extract of the fermented endophytic fungus Trichoderma saturnisporum DI-IA, obtained from the marine sponge Dictyonella incisa, contained conjugated olefinic metabolites with antibacterial activity. Chemical examination of the fungal strain resulted in the isolation of eight new sorbicillinoid-based compounds, namely saturnispols A⁻H (1⁻8). Their structures were determined on the basis of extensive spectroscopic analysis, including the experimental and calculated electronic circular dichroism (ECD) data for the configurational assignments. Saturnispol F exerted significant inhibition against a panel of bacteria strains including vancomycin-resistant enterococci (VRE) with a minimum inhibitory concentrations (MIC) ranging from 1.63 to 12.9 μg/mL, while saturnispol H showed selective effects against VRE and B. subtilis.Entities:
Keywords: Trichoderma saturnisporum; antibacterial effects; marine fungus; saturnispols A–H; structural elucidation
Mesh:
Substances:
Year: 2018 PMID: 29973484 PMCID: PMC6071017 DOI: 10.3390/md16070226
Source DB: PubMed Journal: Mar Drugs ISSN: 1660-3397 Impact factor: 5.118
Figure 1Structures of saturnispols A–H (1–8).
Figure 2Key COSY and HMBC correlations of 1, 3, 5, and 6.
Figure 3Key nuclear overhauser effect (NOE) interactions of 1, 3, and 5.
Figure 4Experimental electronic circular dichroism (ECD) curves of 1 and 2 and the calculated ECD spectra of (±)-1.
1H and 13C NMR data of 1–2 (δ (ppm), J (Hz)).
| 1 a | 2 b | |||
|---|---|---|---|---|
| 1 | 193.6 | 193.1 | ||
| 2 | 105.1 | 104.8 | ||
| 3 | 2.75, d (14.6) 2.47, d (14.6) | 35.1 | 2.83, d (14.0) 2.53, d (14.0) | 35.6 |
| 4 | 72.8 | 72.8 | ||
| 4a | 105.9 | 106.1 | ||
| 5a | 79.2 | 78.9 | ||
| 6 | 168.3 | 166.7 | ||
| 7 | 109.3 | 108.9 | ||
| 8 | 191.9 | 191.7 | ||
| 9 | 101.7 | 101.6 | ||
| 9a | 3.67, s | 53.7 | 3.75, s | 53.8 |
| 9b | 59.2 | 58.7 | ||
| 10 | 177.4 | 179.2 | ||
| 11 | 6.42, d (15.2) | 122.3 | 6.40, d (14.4) | 121.1 |
| 12 | 7.28, dd (11.2, 15.2) | 141.0 | 7.25, dd (14.4, 12.0) | 141.9 |
| 13 | 6.54, dd (11.2, 15.2) | 128.3 | 6.39, dd (14.4, 12.0) | 131.1 |
| 14 | 6.27, dt (5.2, 15.2) | 141.8 | 6.24, dq (14.4, 6.8) | 139,2 |
| 15 | 4.22, t (5.2) | 61.5 | 1.87, d (6.8) | 18.1 |
| 16 | 1.22, s | 21.3 | 1.19, s | 21.5 |
| 17 | 1.45, s | 24.5 | 1.45, s | 25.1 |
| 18 | 1.43, s | 5.74 | 1.45, s | 6.2 |
| 19 | 166.5 | 167.6 | ||
| 20 | 6.62, d (15.2) | 122.5 | 6.72, d (14.4) | 122.8 |
| 21 | 7.25, dd (11.2, 15.2) | 136.9 | 7.25, dd (14.4, 12.0) | 137.1 |
| 22 | 6.54, dd (11.2, 15.2) | 128.9 | 6.63, dd (14.4, 12.0) | 128.6 |
| 23 | 6.18, dt (5.2, 15.2) | 138.6 | 6.23, dd (14.4, 4.6) | 139.9 |
| 24 | 4.22, d (5.2) | 61.6 | 4.23, d (4.6) | 62.1 |
| 25 | 1.29, s | 18.7 | 1.34, s | 19.0 |
a Measured in CD3OD; b measured in acetone-d6.
Figure 5Experimental ECD of 3 and calculated ECD spectra of the isomers of 3.
1H and 13C NMR data of 3–4 (δ (ppm), J (Hz)).
| 3 a | 4 b | |||
|---|---|---|---|---|
| 1 | 64.6 | 64.8 | ||
| 2 | 197.7 | 198.4 | ||
| 3 | 112.0 | 112.9 | ||
| 4 | 3.32, t (2.8) | 40.5 | 3.46, t (2.8) | 40.7 |
| 5 | 74.8 | 73.7 | ||
| 6 | 211.7 | 209.2 | ||
| 7 | 3.15, dd (10.8, 5.6) | 47.7 | 3.24, dd (10.8, 6.0) | 46.4 |
| 8 | 3.05, ddd (13.5, 10.8, 2.8) 1.90, ddd (13.5, 5.6, 2.8) | 31.4 | 3.09, ddd (13.6, 10.8, 2.8) 1.87, ddd (13.6, 6.0, 2.8) | 31.5 |
| 9 | 167.1 | 166.8 | ||
| 10 | 6.30, d (14.8) | 118.1 | 6.75, d (15.2) | 120.3 |
| 11 | 7.41, dd (14.8, 10.8) | 142.4 | 7.43, dd (15.2, 10.8) | 141.0 |
| 12 | 6.33, dd (14.8, 10.8) | 130.9 | 6.68, dd (15.2, 10.8) | 127.7 |
| 13 | 6.25, dq (14.8, 6.8) | 139.7 | 6.39, dt (15.2, 4.4) | 142.9 |
| 14 | 1.94, d (6.8) | 18.9 | 4.28, t (4.4) | 61.7 |
| 15 | 141.4 | 142.1 | ||
| 16 | 6.98, d (7.6) | 128.4 | 7.07, d (7.6) | 128.4 |
| 17 | 7.26, t (7.6) | 128.6 | 7.29, t (7.6) | 128.4 |
| 18 | 7.26, t (7.6) | 127.4 | 7.26, t (7.6) | 127.0 |
| 19 | 7.26, t (7.6) | 128.6 | 7.29, t (7.6) | 128.4 |
| 20 | 6.98, d (7.6) | 128.4 | 7.07, d (7.6) | 128.4 |
| 21 | 0.93, s | 10.5 | 0.80, s | 10.4 |
| 22 | 1.29, s | 24.4 | 1.26, s | 23.2 |
| OH-5 | 2.69, s | 5.05, s | ||
| OH-9 | 14.34, s | 14.40, s | ||
| OH-14 | 4.10, t (4.4) |
a Measured in CDCl3; b measured in acetone-d6.
Figure 6Experimental ECD curves of 3 and 4.
1H NMR data of 5–8 (δ (ppm), J (Hz), 400 MHz).
| 5 a | 6 a | 7 b | 8 a | |
|---|---|---|---|---|
| 4 | 6.01, s | 6.08, s | ||
| 5 | 1.96, dd (12.8, 4.8) 1.66, dd (12.8, 12.0) | 2.07, t (7.6) | ||
| 6 | 2.69, ddd (12.0, 7.4, 4.8) | 2.50, t (7.6) | 6.11, d (16.0) | 6.19, d (15.2) |
| 7 | 4.49, t (7.4) | 6.63, dt (16.0, 7.2) | 7.06, dd (15.2, 10.8) | |
| 8 | 5.65, dd (14.4, 7.4) | 6.18, d (16.0) | 2.32, dt (7.2, 7.6) | 6.45, dd (15.2, 10.8) |
| 9 | 6.31, dd (14.4, 10.6) | 7.25, dd (16.0, 10.6) | 1.71, tt (7.6, 6.4) | 6.15, dt (15.2, 5.0) |
| 10 | 6.29, dd (14.4, 10.6) | 6.47, dd (16.0, 10.6) | 3.61, t (6.4) | 4.20, d (5.0) |
| 11 | 5.86, dt (14.4, 5.6) | 6.36, dt (16.0, 4.6) | 1.89, s | 1.90, s |
| 12 | 4.12, d (5.6) | 4.22, d (4.6) | ||
| 13 | 1.34, s | 1.44, s | ||
| 14 | 1.68, s | 1.66, s |
a Measured in CD3OD; b measured in acetone-d6.
13C NMR data of 5–8.
| 5 a | 6 a | 7 b | 8 a | |
|---|---|---|---|---|
| 1 | 183.2 | 176.8 | 164.4 | 166.7 |
| 2 | 108.4 | 93.6 | 98.9 | 99.2 |
| 3 | 192.2 | 180.8 | 156.1 | 156.5 |
| 4 | 71.1 | 83.0 | 99.6 | 101.4 |
| 5 | 37.1 | 30.6 | 164.8 | 167.1 |
| 6 | 43.9 | 33.7 | 122.2 | 121.9 |
| 7 | 74.2 | 200.6 | 137.1 | 134.0 |
| 8 | 131.6 | 128.5 | 28.8 | 128.4 |
| 9 | 132.3 | 142.9 | 31.8 | 138.4 |
| 10 | 129.4 | 127.4 | 60.7 | 61.6 |
| 11 | 133.5 | 143.6 | 8.0 | 7.2 |
| 12 | 61.7 | 61.4 | ||
| 13 | 24.0 | 22.2 | ||
| 14 | 6.4 | 4.6 |
a Measured in CD3OD; b measured in acetone-d6.
Figure 7Experimental ECD curves of 5 and the calculated ECD spectra of (±)-5.
Figure 8Experimental and calculated ECD spectra of 6.
Scheme 1Postulation of the biogenetic relationship among the isolated compounds.
Antimicrobial activities of compounds 1–8.
| Compounds | MIC (μg/mL) | ||||
|---|---|---|---|---|---|
| VRE | |||||
| >64 | >64 | >64 | >64 | >64 | |
| >64 | >64 | >64 | >64 | >64 | |
| >64 | >64 | >64 | >64 | >64 | |
| >64 | >64 | >64 | >64 | >64 | |
| >64 | >64 | >64 | >64 | >64 | |
| 3.32 | 1.63 | >64 | 6.65 | 6.65 | |
| >64 | >64 | >64 | >64 | >64 | |
| >64 | 12.9 | 12.9 | >64 | >64 | |
| ciprofloxacin | 0.125 | ND | 0.125 | ND | ND |
| colistin | ND | ND | ND | 0.125 | 0.125 |
| bacaucin | ND | 16 | ND | ND | ND |
MIC: minimum inhibitory concentrations, ND = no detection.